Saturday March 2, 2019
IPF AND AROUNDChairs: Martin Kolb (Hamilton, ON - Canada), Michael Kreuter (Heidelberg, Germany), Carlo Vancheri (Catania, Italy)
14.00 What we learned from basic science studies on IPF?
Martin Kolb (Hamilton, ON - Canada)
14.20 Cryobiopsy: lesson learned and future perspectives
Alberto Cavazza (Reggio Emilia, Italy)
14.40 The role of imaging in fibrotic lung disease
Maurizio Zompatori (Milan, Italy)
15.00 Comorbidities on IPF: an underestimate issue
Antonella Caminati (Milan, Italy)
HOT TOPICS IN FIBROTIC LUNG DISEASEChairs: Sergio Harari (Milan, Italy), Venerino Poletti (Forlì, Italy), Ganesh Raghu (Seattle, WA - USA)
15.50 Genetic and epigenetic factors in IPF
Bruno Crestani (Paris, France)
16.10 Hypersensitivity pneumonitis
Toby M. Maher (London, United Kingdom)
16.30 Antifibrotic therapy: only for IPF patients?
Ganesh Raghu (Seattle, WA - USA)
16.50 The therapy of IPF: what’s next?
Michael Kreuter (Heidelberg, Germany)
17.30 Closing remarks